USPTO 2015–2025 USPTO PatentsView US Corporation

Terumo BCT Biotechnologies, LLC

USPTO PatentsView assignee record - 13 granted patents across 9 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Terumo ranks #21,886 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 9 technology areas.

#21,886
of 49,997 US assignees by volume
Top 10%
by Innovation Score (52.6/100)
21.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R21886 · US Corporation #21,886 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 13 grants
  • MID-PACK #21,886/49,997
  • PHOTO-FINISH Techspace Aero
  • CPC-NARROW A61M · 9 areas
  • INNOV-PAR 52.6/100
  • CLAIMS-DENSE 21.5 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2020–2025 · 6y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Techspace Aero S.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Terumo

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Terumo's Innovation Score is 52.6/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Terumo's grants concentrate

Terumo BCT Biotechnologies, LLC is a focused PatentsView assignee: 9 CPC subclasses with 76.9% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2023 (8 grants) versus a trough of 1 in 2020. By volume, Terumo sits between Techspace Aero S.A. and The Board of Trustees of the University of Alabama, for and on behalf of the University of Alabama in Huntsville.

Terumo's three-year grant acceleration

Terumo BCT Biotechnologies, LLC shows 11 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Terumo's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Terumo holds 13 patents at rank #21,923, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Terumo

By rank, the assignees closest to #21,923 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Terumo's primary technology class.

Terumo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 10% higher than 90% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 20202022202320242025 1
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Terumo BCT Biotechnologies, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 7.7%
2022 1 7.7%
2023 8 61.5%
2024 2 15.4%
2025partial year 1 7.7%

Which technologies does Terumo BCT Biotechnologies, LLC patent most?

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#21,886

of 49,997 tracked assignees

Innovation Score

52.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Terumo BCT Biotechnologies, LLC's patent record in context - here's where to go next.

  • Terumo BCT Biotechnologies, LLC's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 76.9% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #21,886 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Terumo BCT Biotechnologies, LLC against Techspace Aero S.A., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 52.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.